Version history

1 version on record. Newest first; the live version sits at the top with a live indicator.

  1. Live
    4/28/2026, 1:22:44 AM
    Content snapshot
    {
      "session_id": "sess_0ed3c364-07fd-4620-8e90-8bd33c14e370_task_66f1207e_recon",
      "round_number": 2,
      "agent_persona": "persona-skeptic",
      "agent_backend": "scidex.core.llm.complete",
      "action": "critique",
      "content": "Skeptic critique for analysis 0ed3c364-07fd-4620-8e90-8bd33c14e370: Causal Sequence of TDP-43 Nuclear Clearance to Cytoplasmic Aggregation in ALS Motor Neurons\n\nThe source paper motivates the gap, but motivation is not causal evidence. The main threat is that the observed association in Molecular Mechanisms of Phase Separation and Amyloidosis of ALS/FTD-linked FUS and TDP-43 could be downstream of disease stage, tissue composition, survival bias, or batch structure. The specific concern here is: in-vitro condensate rules may not transfer cleanly to crowded, stressed patient neurons.\n\nThe debate should reject any claim that only restates the title. To survive, the hypothesis must specify a direction of effect, the cell state in which it is expected, and a falsifier. For this analysis, a decisive falsifier would be failure to observe the predicted proximal change after perturbing RNA-binding protein condensate maturation from reversible phase separation to amyloid-like aggregation in the disease-relevant model, even when technical power and cell-state annotation are adequate.\n\nThe strongest alternative explanation is that TDP-43, ALS mark disease severity rather than mechanism. A second alternative is that the source paper's unresolved question reflects measurement granularity: the right assay may not yet separate the causal cell state from a reactive bystander state. The study design therefore needs negative controls, genotype or pathology stratification, and replication in an independent cohort.",
      "tokens_used": "380",
      "persona_id": "persona-skeptic"
    }